Abbott CEO Says 'We're Sorry About The Baby Formula Shortage,' Ensures Significant Investment For Future


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Abbott Laboratories (NYSE:ABT) Chief Executive Robert Ford apologized Saturday for his company's role in the nationwide shortage of baby formula and promised production would ramp up again in June. 

"We're sorry to every family we've let down," Mr. Ford wrote in a Washington Post op-ed. "We are making significant investments to ensure this never happens again," he wrote. 

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

In February, Abbott voluntarily recalled some of its Similac, Alimentum, and EleCare formulas manufactured in its Sturgis, Michigan plant after the FDA officials found a potentially deadly bacteria there. 

That decision exacerbated an existing baby formula shortage created by supply-chain issues during the pandemic, Mr. Ford acknowledged.

Related: Danone Scales Up Baby Formula Shipments To US To Combat Shortage

Four infants who drank tainted baby formula were hospitalized, and two of them died. However, the FDA said the bacteria didn't match the strains found at the Abbott plant. Mr. Ford wrote that issuing a voluntary recall was the right thing to do. 

Ford said the company plans to restart its Sturgis facility in early June after entering into a consent decree with the FDA. It will take six to eight weeks from when production begins to get products on the shelves. 

"When we are operating our Michigan facility at full capacity, we will more than double our current production of powdered infant formula for the United States. We will be supplying more formula to Americans than we were in January before the recall by the end of June," Ford added.

Price Action: ABT shares closed at $113.24 on Monday.

Photo via Company


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: Large CapNewsHealth CareGeneral